- Home
- ICCM vs FORA Comparison
ICCM vs FORA Comparison
Compare ICCM & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | FORA |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 66.2M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ICCM | FORA |
|---|---|---|
| Price | $0.73 | $2.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 180.6K | 15.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | $19.87 | $51.82 |
| Revenue Next Year | $31.38 | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $1.64 |
| 52 Week High | $1.52 | $2.71 |
Technical Indicators
Market Signals| Indicator | ICCM | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 68.80 | 37.28 |
| Support Level | $0.68 | $2.05 |
| Resistance Level | $0.74 | $2.12 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 96.44 | 16.67 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.